This report on Angiogenesis Modulators studies the impact of Inhibitors and Stimulators on various diseases. The study focuses on major angiogenesis inhibitors and their role in diseases such as cancer, cardiology, ophthalmology, and other angiogenesis based diseases including endometriosis and inflammatory diseases. The emphasis is also given on major angiogenesis stimulators and their role in diseases such as cardiovascular disorders including ischemia, congestive heart failure, coronary artery disease, myocardial infarction and peripheral vascular disease and chronic wound care. http://bharatbook.com/market-research-reports/biotechnology-market-research-report/angiogenesis-modulators.html
 
 The study provides global market analysis for angiogenesis therapeutic products by the above angiogenesis modulators and also by the disease areas such as cancer, cardiovascular disorders and other angiogenesis based diseases. Compilation of Worldwide Patents and Research related to Angiogenesis is also provided. The study includes estimations and predictions for the total global angiogenesis therapeutic products market. Estimations and predictions are also graphically illustrated by geographic regions encompassing the US, Europe, Asia-Pacific and Rest of World. Marketing Research Companies
 
 Report Highlights
 
 This report may help strategists, investors, laboratories, contract research organizations, biotechnology & Healthcare companies, academic professionals, drug approval authorities, and other organizations to –
 * Identify Market Opportunities
 * Review and Analyze Global and Regional Markets
 * Gauge Market Potential for your Products
 * Identify Competition
 * Use Market Research for exploring new areas
 * Acquire Meaningful Guidelines for Strategic Planning
 * Gear up for Market Entry
 * Get Actionable Information
 
 Analytics and data presented in each report pertain to several parameters such as –
 * Global and Regional Market Sizes, Market Shares, Market Trends
 * Product (Global and Regional) Market Sizes, Market Shares, Market Trends
 * Technology Trends
 * Corporate Intelligence
 * Key Companies By Sales, Brands, Products
 * Other Strategic Business Affecting Data
 
 Key Report Findings
 Global angiogenesis therapeutic products market is projected to grow at 33.57% compounded annually from 2005 through 2015. This growth is driven by aging and growing populations in the US, Europe and Japan. Apart from cancer, the growth would be also owing to the increased cardiovascular diseases such as ischemia, congestive heart failure, myocardial infarction etc. Industry consolidations are marking the industry as more and more pharmaceutical companies are trying to acquire R&D outfits, and other small biotech companies engaged in angiogenesis products.
 
 Angiogenesis plays a prominent role in development and expansion of cancer cells. The new blood vessel formed supplies the cancer tumor with the required oxygen and nutrients, thus facilitating its expansion to the neighboring regions. Both natural and synthetic angiogenesis inhibitors are under development for different therapeutic areas such as Oncology, Central Nervous System, Dermatology, and Ophthalmology. Use of Cartilage (Shark) derived Inhibitor is been used widely as a secondary treatment of non-responsive solid cancer tumors. Development of ‘proteosome’ is expected to attract more patients towards anti-angiogenesis therapy for the treatment of various tumor types.
 
 For more information kindly visit :
 Report on Angiogenesis Modulators studies the impact of Inhibitors
 
 Or
 
 Bharat Book Bureau
 Tel: +91 22 27810772 / 27810773
 Fax: + 91 22 27812290
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: http://twitter.com/#!/Sandhya3B